Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Cornell

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Archives of Dermatology|July 1, 1973
Azaribine in the treatment of psoriasis. A low dose, double-blind evaluationH G Milstein, R C Cornell, R B Stoughton
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2001
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia AC Leissinger, D Becton, C Cornell, et al.
British Journal of Cancer|August 1, 1991
Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasisS Thompson, B M Cantwell, C Cornell, et al.
British Journal of Urology|May 1, 1987
Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostateP D Abel, C Cornell, P K Buamah, et al.
Clinical Therapeutics|January 1, 1986
Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasisI Willis, R C Cornell, N S Penneys, et al.
International Journal of Cancer|October 21, 1993
Possible regulation of soluble ICAM-1 levels by interleukin-1 in a sub-set of breast cystsL C Lai, S Kadory, C Cornell, et al.
Plastic and Reconstructive Surgery|February 1, 1994
The use of Mitek anchors to secure mesh in abdominal wall reconstructionK R Francis, L A Hoffman, C Cornell, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1987
An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancerP K Buamah, C Cornell, C W Venables, et al.
Clinical Chemistry|May 1, 1986
Concentrations of trypsin, elastase and carbohydrate antigen CA 19-9 in serum of cystic fibrosis patientsP K Buamah, C Cornell, A J Cassells-Smith, et al.
Diabetes|December 1, 1995
NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic communityJ A Pugh, R A Medina, J C Cornell, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Archives of Dermatology|July 1, 1973
Azaribine in the treatment of psoriasis. A low dose, double-blind evaluationH G Milstein, R C Cornell, R B Stoughton
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 16, 2001
High-dose DDAVP intranasal spray (Stimate) for the prevention and treatment of bleeding in patients with mild haemophilia A, mild or moderate type 1 von Willebrand disease and symptomatic carriers of haemophilia AC Leissinger, D Becton, C Cornell, et al.
British Journal of Cancer|August 1, 1991
Abnormally-fucosylated haptoglobin: a cancer marker for tumour burden but not gross liver metastasisS Thompson, B M Cantwell, C Cornell, et al.
British Journal of Urology|May 1, 1987
Assessment of serum CA 19.9 as a tumour marker in patients with carcinoma of the bladder and prostateP D Abel, C Cornell, P K Buamah, et al.
Clinical Therapeutics|January 1, 1986
Multicenter study comparing 0.05% gel formulations of desoximetasone and fluocinonide in patients with scalp psoriasisI Willis, R C Cornell, N S Penneys, et al.
International Journal of Cancer|October 21, 1993
Possible regulation of soluble ICAM-1 levels by interleukin-1 in a sub-set of breast cystsL C Lai, S Kadory, C Cornell, et al.
Plastic and Reconstructive Surgery|February 1, 1994
The use of Mitek anchors to secure mesh in abdominal wall reconstructionK R Francis, L A Hoffman, C Cornell, et al.
European Journal of Cancer & Clinical Oncology|January 1, 1987
An initial appraisal of the value of serum carbohydrate antigenic determinant (CA 19-9) levels in patients with pancreatic cancerP K Buamah, C Cornell, C W Venables, et al.
Clinical Chemistry|May 1, 1986
Concentrations of trypsin, elastase and carbohydrate antigen CA 19-9 in serum of cystic fibrosis patientsP K Buamah, C Cornell, A J Cassells-Smith, et al.
Diabetes|December 1, 1995
NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic communityJ A Pugh, R A Medina, J C Cornell, et al.
Pageof 8